Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-11,609
Closed -$62K 775
2021
Q4
$62K Buy
+11,609
New +$56.5K ﹤0.01% 708
2021
Q3
Sell
-13,797
Closed -$63K 729
2021
Q2
$63K Buy
+13,797
New +$57.9K ﹤0.01% 672
2020
Q3
Sell
-21,783
Closed -$36K 531
2020
Q2
$36K Buy
+21,783
New +$30.1K ﹤0.01% 491
2020
Q1
Sell
-26,439
Closed -$118K 498
2019
Q4
$118K Buy
26,439
+1,976
+8% +$7.72K 0.02% 455
2019
Q3
$104K Buy
24,463
+12,695
+108% +$44K 0.01% 436
2019
Q2
$39K Buy
+11,768
New +$42.3K 0.01% 405

Other funds holding VRN

Corient Capital Partners's VRN Position: Q1 2022 in Review

Corient Capital Partners sold out of Veren (VRN) in Q1 2022, closing a stake of 11,609 shares — an estimated $62K sold.

Corient Capital Partners first reported a position in VRN in Q2 2019 and held it in 6 quarters. The position peaked at $118K in Q4 2019. 168 funds tracked by Wall St. Rank hold VRN as of Q1 2022.

  • Corient Capital Partners reported no remaining Veren position as of Q1 2022 after selling out during the quarter.
  • Corient Capital Partners sold 11,609 Veren shares in Q1 2022, an estimated $62K.
  • Corient Capital Partners first reported a position in Veren in Q2 2019 and held it in 6 quarters.
  • Corient Capital Partners's Veren position peaked at $118K in Q4 2019.
  • 168 funds tracked by Wall St. Rank held Veren as of Q1 2022.

Based on Corient Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.